Raphaël Depaz
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
- Rheumatology top 10%
- IgG4-Related and Inflammatory Diseases
- Systemic Lupus Erythematosus Research
Papers in
-
- Multiple Sclerosis Research Studies 6
-
- Peripheral Neuropathies and Disorders 4
- Co-authors
- Patrice Cacoub (2 shared papers)David Saadoun (2 shared papers)Olivier Gout (4 shared papers)R Bernard (1 shared paper)B. Wechsler (1 shared paper)Didier Dormont (1 shared paper)Du Le Thi Huong Boutin (1 shared paper)Jean‐Charles Piette (1 shared paper)
In The Last Decade
Raphaël Depaz
15 papers receiving 364 citations
Peers
Comparison fields: 5 of 42
- Ophthalmology 154
- Rheumatology 89
- Pathology and Forensic Medicine 98
- Neurology 81
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Raphaël Depaz
This map shows the geographic impact of Raphaël Depaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Depaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Depaz more than expected).
Fields of papers citing papers by Raphaël Depaz
This network shows the impact of papers produced by Raphaël Depaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Depaz. The network helps show where Raphaël Depaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphaël Depaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 100 | |
| 2 | 2016 | 57 | |
| 3 | 2016 | 49 | |
| 4 | 2013 | 42 | |
| 5 | 2011 | 25 | |
| 6 | 2011 | 17 | |
| 7 | 2021 | 17 | |
| 8 | 2019 | 17 | |
| 9 | 2024 | 14 | |
| 10 | 2020 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2013 | 7 | |
| 13 | 2011 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2013 | 1 |
About Raphaël Depaz
Raphaël Depaz is a scholar working on Pathology and Forensic Medicine, Neurology, Ophthalmology, Rheumatology and Epidemiology, having authored 15 papers that have together received 373 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (4 papers), Ocular Diseases and Behçet’s Syndrome (2 papers), Retinal and Optic Conditions (2 papers), Herpesvirus Infections and Treatments (2 papers), IgG4-Related and Inflammatory Diseases (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Ophthalmology (154 citations), Rheumatology (89 citations), Pathology and Forensic Medicine (98 citations), Neurology (81 citations) and Pulmonary and Respiratory Medicine (48 citations). Raphaël Depaz has collaborated with scholars based in France, Italy and Réunion. Frequent co-authors include Patrice Cacoub, David Saadoun, Olivier Gout, R Bernard, B. Wechsler, Didier Dormont, Du Le Thi Huong Boutin, Jean‐Charles Piette, Matthieu Resche‐Rigon and Romain Deschamps. Their work appears in journals such as Multiple Sclerosis Journal, British Journal of Ophthalmology, Arthritis & Rheumatology, Neurology Neuroimmunology & Neuroinflammation and Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.